H. Yin

First name
H.
Last name
Yin
Lu, S., Yin, H., H. Y. Yu, O., & Azoulay, L. (2022). Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000001486
Chowdhury, R., Michaud, J., H. Y. Yu, O., Yin, H., Azoulay, L., & Renoux, C. (2022). Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus. Thromb Haemost. http://doi.org/10.1055/a-1798-2116
Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., et al. (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021
Pradhan, R., Yin, H., Yu, O., & Azoulay, L. (2022). Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1953
Azoulay, L., Yin, H., Renoux, C., & Suissa, S. (2011). The use of atypical antipsychotics and the risk of breast cancer. Breast Cancer Res Treat. http://doi.org/10.1007/s10549-011-1506-2
Azoulay, L., Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., & Suissa, S. (2011). Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol. http://doi.org/10.1016/j.eururo.2011.08.041
Azoulay, L., Assimes, T. L., Yin, H., Bartels, D. B., Schiffrin, E. L., & Suissa, S. (2012). Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One. http://doi.org/10.1371/journal.pone.0050893
Azoulay, L., Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., & Suissa, S. (2012). The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. Bmj. http://doi.org/10.1136/bmj.e3645
Smiechowski, B., Azoulay, L., Yin, H., Pollak, M. N., & Suissa, S. (2013). The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-13-0196
Smiechowski, B. B., Azoulay, L., Yin, H., Pollak, M. N., & Suissa, S. (2013). The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care. http://doi.org/10.2337/dc12-0740